MedicaidPrior AuthHigh impact
Alaska Medicaid Pharmacy Update September 2022
Alaska Medicaid·AK · Pharmacy·Pharmacy
Effective date
Nov 1, 2022
We identified it
Jun 21, 2026
Summary
Alaska Medicaid is implementing major pharmacy changes effective November 1, 2022, including a new Preferred Drug List (PDL), updated prior authorization requirements for specific high-cost medications like Evrysdi and Spinraza, and adding 35 new medications to the interim prior authorization list. Some prior authorization requirements for proton pump inhibitors, long-acting beta agonist inhalations, and linezolid tablets will be removed.
Action Required
By November 1, 2022: Billing team must update prior authorization workflows for newly added medications including Evrysdi, Spinraza, and 35 new-to-market drugs listed in the policy. Remove prior authorization requirements for proton pump inhibitors, long-acting beta agonist inhalations, and linezolid tablets. Providers must check PDMP before prescribing opioids and ensure ICD-10 codes are included for C-II opioid prescriptions. Visit Alaska Medicaid's prior authorization webpage to download updated forms and criteria. Claims for affected medications without proper prior authorization will be denied.